-
1دورية أكاديمية
المؤلفون: Rattotti S., Ferretti V. V., Rusconi C., Rossi A., Fogazzi S., Baldini L., Pioltelli P., Balzarotti M., Farina L., Ferreri A. J. M., Laszlo D., Speziale V., Varettoni M., Sciarra R., Morello L., Tedeschi A., Frigeni M., Defrancesco I., Zerbi C., Flospergher E., Nizzoli M. E., Morra E., Arcaini L.
المساهمون: Rattotti, S., Ferretti, V. V., Rusconi, C., Rossi, A., Fogazzi, S., Baldini, L., Pioltelli, P., Balzarotti, M., Farina, L., Ferreri, A. J. M., Laszlo, D., Speziale, V., Varettoni, M., Sciarra, R., Morello, L., Tedeschi, A., Frigeni, M., Defrancesco, I., Zerbi, C., Flospergher, E., Nizzoli, M. E., Morra, E., Arcaini, L.
مصطلحات موضوعية: antiviral therapy, chronic hepatitis C virus infection, cohort study, non-Hodgkin lymphoma, Adult, Aged, 80 and over, Disease-Free Survival, Female, Follow-Up Studie, Human, Interferon, Italy, Male, Middle Aged, Prospective Studie, Survival Rate, Hepaciviru, Hepatitis C, Chronic, Lymphoma, Non-Hodgkin
وصف الملف: STAMPA
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30726562; info:eu-repo/semantics/altIdentifier/wos/WOS:000466180700006; volume:37; issue:2; firstpage:160-167; lastpage:167; journal:HEMATOLOGICAL ONCOLOGY; http://hdl.handle.net/11571/1363336Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85061962957
-
2دورية أكاديمية
المؤلفون: Pagano L., Criscuolo M., Galli E., Storti S., Fianchi L.
المساهمون: Pagano, Livio, Criscuolo, Marianna, Broccoli, A., Piciocchi, A., Varettoni, M., Galli, Eugenio, Anastasia, A., Cantonetti, M., Trentin, L., Kovalchuk, S., Orsucci, L., Frustaci, A., Spolzino, A., Volpetti, S., Annibali, O., Storti, Sergio, Stelitano, C., Marchesi, F., Offidani, M., Casadei, B., Nizzoli, M. E., De Luca, M. L., Fianchi, Luana, Motta, M., Guarnera, L., Simonetti, E., Visentin, A., Vassallo, F., Deodato, M., Sarlo, C., Olivieri, A., Falini, B., Pulsoni, A., Tiacci, E., Zinzani, P. L.
مصطلحات موضوعية: Adult, Aged, 80 and over, Cladribine, Follow-Up Studies, Humans, Middle Aged, Recurrence, Remission Induction, Retrospective Studies, Treatment Outcome, Young Adult, Antineoplastic Agents, Leukemia, Hairy Cell, Settore MED/15 - MALATTIE DEL SANGUE
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35853850; info:eu-repo/semantics/altIdentifier/wos/WOS:000827732900001; volume:12; issue:7; firstpage:109; lastpage:120; numberofpages:12; issueyear:2022; journal:BLOOD CANCER JOURNAL; https://hdl.handle.net/10807/223791Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85134416463
